Postmortem molecular analysis of KCNQ1, KCNH2, KCNE1 and KCNE2 genes in sudden unexplained nocturnal death syndrome in the Chinese Han population

Forensic Science International

Volumn 231, Issue 1-3, 2013, Pages 82-87

  Liu, Chao ^a   Zhao, Qianhao ^b   Su, Terry ^b   Tang, Shuangbo ^b   Lv, Guoli ^a   Liu, Hong ^a   Quan, Li ^b   Cheng, Jianding ^b  

^a Guangzhou Institute of Criminal Science and Technology   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cardiac potassium channel; Gene; Mutation; Single nucleotide polymorphism (SNP); Sudden unexplained nocturnal death syndrome

Indexed keywords

GENOMIC DNA; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNE2; POTASSIUM CHANNEL KCNQ1;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; AUTOPSY; CHINA; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; KCNE1 GENE; KCNE2 GENE; KCNH2 GENE; KCNQ1 GENE; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN DEATH;

EID: 84878819027     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2013.04.020     Document Type: Article

References (40)

1. Cheng J., Makielski J.C., Yuan P., Shi N., Zhou F., Ye B., Tan B.H., Kroboth S. Sudden unexplained nocturnal death syndrome in southern China: an epidemiological survey and SCN5A gene screening. Am. J. Forensic Med. Pathol. 2011, 32:359-363.
2. Gervacio-Domingo G., Punzalan F.E., Amarillo M.L., Dans A. Sudden unexplained death during sleep occurred commonly in the general population in the Philippines: a sub study of the National Nutrition and Health Survey. J. Clin. Epidemiol. 2007, 60:567-571.
3. Vatta M., Dumaine R., Varghese G., Richard T.A., Shimizu W., Aihara N., Nademanee K., Brugada R., Brugada J., Veerakul G., Li H., Bowles N.E., Brugada P., Antzelevitch C., Towbin J.A. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum. Mol. Genet. 2002, 11:337-345.
4. Rubart M., Zipes D.P. Mechanisms of sudden cardiac death. J. Clin. Invest. 2005, 115:2305-2315.
5. Schimpf R., Veltmann C., Wolpert C., Borggrefe M. Arrhythmogenic hereditary syndromes: Brugada Syndrome, long QT syndrome, short QT syndrome and CPVT. Minerva Cardioangiol. 2010, 58:623-636.
6. Kiehne N., Kauferstein S. Mutations in the SCN5A gene: evidence for a link between long QT syndrome and sudden death?. Forensic Sci. Int. Genet. 2007, 1:170-174.
7. Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S., Robinson J.L., Moss A.J., Schwartz P.J., Towbin J.A., Vincent G.M., Keating M.T. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000, 102:1178-1185.
8. Modell S.M., Lehmann M.H. The long QT syndrome family of cardiac ion channelopathies: a HuGE review. Genet. Med. 2006, 8:143-155.
9. Chiang C.E. Congenital and acquired long QT syndrome. Current concepts and management. Cardiol. Rev. 2004, 12:222-234.
10. Rodriguez-Calvo M.S., Brion M., Allegue C., Concheiro L., Carracedo A. Molecular genetics of sudden cardiac death. Forensic Sci. Int. 2008, 182:1-12.
11. Zhou F., Li H., Zhang J., Tang S., Lu C., Cheng J. The screening of SCN5A mutations in sudden unexpected nocturnal death syndrome in Chinese Han nationality population. Int. J. Intern. Med. 2009, 1:1-4.
12. Splawski I., Shen J., Timothy K.W., Vincent G.M., Lehmann M.H., Keating M.T. Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics 1998, 51:86-97.
13. Gouas L., Nicaud V., Berthet M., Forhan A., Tiret L., Balkau B., Guicheney P. Association of KCNQ1, KCNE1, KCNH2 and SCN5A polymorphisms with QTc interval length in a healthy population. Eur. J. Hum. Genet. 2005, 13:1213-1222.
14. George A.J. Association of a common KCNE1 variant with heart failure. Heart Rhythm 2010, 7:368-369.
15. Kubota T., Horie M., Takano M., Yoshida H., Takenaka K., Watanabe E., Tsuchiya T., Otani H., Sasayama S. Evidence for a single nucleotide polymorphism in the KCNQ1 potassium channel that underlies susceptibility to life-threatening arrhythmias. J. Cardiovasc. Electrophysiol. 2001, 12:1223-1229.
16. Itoh T., Tanaka T., Nagai R., Kamiya T., Sawayama T., Nakayama T., Tomoike H., Sakurada H., Yazaki Y., Nakamura Y. Genomic organization and mutational analysis of HERG, a gene responsible for familial long QT syndrome. Hum. Genet. 1998, 102:435-439.
17. Abbott G.W., Sesti F., Splawski I., Buck M.E., Lehmann M.H., Timothy K.W., Keating M.T., Goldstein S.A. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999, 97:175-187.
18. Gaw A.C., Lee B., Gervacio-Domingo G., Antzelevitch C., Divinagracia R., Jocano F.J. Unraveling the enigma of Bangungut: is sudden unexplained nocturnal death syndrome (SUNDS) in the Philippines a disease allelic to the Brugada syndrome?. Philipp. J. Intern. Med. 2011, 49:165-176.
19. Ma L., Lin C., Teng S., Chai Y., Bahring R., Vardanyan V., Li L., Pongs O., Hui R. Characterization of a novel long QT syndrome mutation G52R-KCNE1 in a Chinese family. Cardiovasc. Res. 2003, 59:612-619.
20. Tapper A.R., George A.J. MinK subdomains that mediate modulation of and association with KvLQT1. J. Gen. Physiol. 2000, 116:379-390.
21. Fitch W.M. The large extent of putative secondary nucleic acid structure in random nucleotide sequences or amino acid derived messenger-RNA. J. Mol. Evol. 1974, 3:279-291.
22. Klambt D. A model for messenger RNA sequences maximizing secondary structure due to code degeneracy. J. Theor. Biol. 1975, 52:57-65.
23. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., Gejman P.V. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 2003, 12:205-216.
24. Duan J., Antezana M.A. Mammalian mutation pressure, synonymous codon choice, and mRNA degradation. J. Mol. Evol. 2003, 57:694-701.
25. Krawczak M., Reiss J., Cooper D.N. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum. Genet. 1992, 90:41-54.
26. Gong Q., Zhang L., Moss A.J., Vincent G.M., Ackerman M.J., Robinson J.C., Jones M.A., Tester D.J., Zhou Z. A splice site mutation in hERG leads to cryptic splicing in human long QT syndrome. J. Mol. Cell. Cardiol. 2008, 44:502-509.
27. Lai L.P., Deng C.L., Moss A.J., Kass R.S., Liang C.S. Polymorphism of the gene encoding a human minimal potassium ion channel (minK). Gene 1994, 151:339-340.
28. Paulussen A.D., Gilissen R.A., Armstrong M., Doevendans P.A., Verhasselt P., Smeets H.J., Schulze-Bahr E., Haverkamp W., Breithardt G., Cohen N., Aerssens J. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J. Mol. Med. (Berl.) 2004, 82:182-188.
29. Husser D., Stridh M., Sornmo L., Roden D.M., Darbar D., Bollmann A. A genotype-dependent intermediate ECG phenotype in patients with persistent lone atrial fibrillation genotype ECG-phenotype correlation in atrial fibrillation. Circ. Arrhythm Electrophysiol. 2009, 2:24-28.
30. Fatini C., Sticchi E., Marcucci R., Verdiani V., Nozzoli C., Vassallo C., Emdin M., Abbate R., Gensini G.F. S38G single-nucleotide polymorphism at the KCNE1 locus is associated with heart failure. Heart Rhythm 2010, 7:363-367.
31. Akyol M., Jalilzadeh S., Sinner M.F., Perz S., Beckmann B.M., Gieger C., Illig T., Wichmann H.E., Meitinger T., Kaab S., Pfeufer A. The common non-synonymous variant G38S of the KCNE1-(minK)-gene is not associated to QT interval in Central European Caucasians: results from the KORA study. Eur. Heart J. 2007, 28:305-309.
32. Pietila E., Fodstad H., Niskasaari E., Laitinen P.P., Swan H., Savolainen M., Kesaniemi Y.A., Kontula K., Huikuri H.V. Association between HERG K897T polymorphism and QT interval in middle-aged Finnish women. J. Am. Coll. Cardiol. 2002, 40:511-514.
33. Koo S.H., Ho W.F., Lee E.J. Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore. Br. J. Clin. Pharmacol. 2006, 61:301-308.
34. Paavonen K.J., Chapman H., Laitinen P.J., Fodstad H., Piippo K., Swan H., Toivonen L., Viitasalo M., Kontula K., Pasternack M. Functional characterization of the common amino acid 897 polymorphism of the cardiac potassium channel KCNH2 (HERG). Cardiovasc. Res. 2003, 59:603-611.
35. Bezzina C.R., Verkerk A.O., Busjahn A., Jeron A., Erdmann J., Koopmann T.T., Bhuiyan Z.A., Wilders R., Mannens M.M., Tan H.L., Luft F.C., Schunkert H., Wilde A.A. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc. Res. 2003, 59:27-36.
36. Newton-Cheh C., Guo C.Y., Larson M.G., Musone S.L., Surti A., Camargo A.L., Drake J.A., Benjamin E.J., Levy D., D'Agostino R.S., Hirschhorn J.N., O'Donnell C.J. Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study. Circulation 2007, 116:1128-1136.
37. Sinner M.F., Pfeufer A., Akyol M., Beckmann B.M., Hinterseer M., Wacker A., Perz S., Sauter W., Illig T., Nabauer M., Schmitt C., Wichmann H.E., Schomig A., Steinbeck G., Meitinger T., Kaab S. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur. Heart J. 2008, 29:907-914.
38. Yang P., Kanki H., Drolet B., Yang T., Wei J., Viswanathan P.C., Hohnloser S.H., Shimizu W., Schwartz P.J., Stanton M., Murray K.T., Norris K., George A.J., Roden D.M. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation 2002, 105:1943-1948.
39. Sharma D., Glatter K.A., Timofeyev V., Tuteja D., Zhang Z., Rodriguez J., Tester D.J., Low R., Scheinman M.M., Ackerman M.J., Chiamvimonvat N. Characterization of a KCNQ1/KVLQT1 polymorphism in Asian families with LQT2: implications for genetic testing. J. Mol. Cell. Cardiol. 2004, 37:79-89.
40. Tester D.J., Medeiros-Domingo A., Will M.L., Haglund C.M., Ackerman M.J. Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. Mayo Clin. Proc. 2012, 87:524-539.